Pharmaceutical manufacturing, exporting, and supplying of medicines in India.
Annual revenue $72,601 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About DAASO Pharma

DAASO Pharma is a company. DAASO Pharma offers products and services including Synapse Plus and Q Carni 10.

Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $72.6 K (USD)
    128.11
    as on Mar 31, 2020
  • Net Profit
    $4.4 K (USD)
    568.58
    as on Mar 31, 2020
  • EBITDA
    $11.33 K (USD)
    1348.16
    as on Mar 31, 2020
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DAASO Pharma

DAASO Pharma offers a comprehensive portfolio of products and services, including Synapse Plus and Q Carni 10.

Product name locked
Category locked
Primary

A high-strength Omega-3 FA and Vitamin D-3 syrup is provided for health support

Product name locked
Category locked
Locked

High-strength L Carnitine with Co enzyme Q10 syrup is supplied to boost mitochondrial functions

Funding Insights of DAASO Pharma

Premium access

Detailed funding history for DAASO Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by DAASO Pharma

Investments
Premium access

Investment portfolio details for DAASO Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - DAASO Pharma

Premium access

Detailed financials for DAASO Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Daaso Pharma Comparisons

DAASO Pharma Primary company
Description
Pharmaceutical manufacturing, exporting, and supplying of me...
Location
-
Founded Year
-
Annual Revenue
$72.6 K (USD)
Net Profit
$4.4 K (USD)
EBITDA
$11.33 K (USD)
Employees
Not available
Premium access

Peer comparison for DAASO Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of DAASO Pharma

Premium access

Detailed competitors of DAASO Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Daaso Pharma

Premium access

Complete news archive for DAASO Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DAASO Pharma

Annual revenue of DAASO Pharma is $72.6K as on Mar 31, 2020.

DAASO Pharma is recognized as an upcoming and fast-growing pharmaceutical company that emphasizes the delivery of scientifically designed combinations with a promise of highest quality. A focus is placed on ensuring these products are cost-effective and accessible to a larger segment of society, aligning with the vision of a healthy and strong India. Quality is prioritized through well-tested formulations in dietary supplements and medicines, while efforts are made to meet market demands without compromise.

DAASO Pharma offers Synapse Plus and Q Carni 10.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available